USA – Japanese drugmaker Eisai Co. has filed for a faster approval process with the FDA for the approval of its experimental drug for Alzheimer’s disease (AD), lecanemab. The request…
Read MoreEisai and Biogen seeking FDA fast approval for novel Alzheimer’s drug
